Tromantadine inhibits a late step in herpes simplex virus type 1 replication and syncytium formation

Dawn E. Ickes, Tom M. Venetta, Yupa Phonphok, Ken S. Rosenthal

Research output: Contribution to journalArticle

Abstract

Addition of tromantadine after virus penetration inhibited HSV-1 induced syncytium formation and virus production in HEp-2 and VERO cells and acted additively with neutralizing antibody in blocking virus spread and cytopathology. Inhibition of syncytium formation in VERO cells infected with 0.01 pfu/cell of HSV-1 GC+ was observed at a concentration <25 μg/ml. The extent of inhibition was dependent upon the multiplicity of infection and cell type. Tromantadine inhibited a late event in HSV-1 replication which appeared to be sensitive to cycloheximide. Reversal of the inhibitory effect of tromantadine on syncytium formation required new protein synthesis. HSV-1 gB, gC, and gD were synthesized in the presence of tromantadine and could be detected on the cell surface by immunofluorescence. Tromantadine most likely inhibits a cellular process that is required for syncytium formation, such as glycoprotein processing, which occurs after the synthesis of the fusion protein but before its expression on the cell surface.

Original languageEnglish (US)
Pages (from-to)75-85
Number of pages11
JournalAntiviral Research
Volume14
Issue number2
DOIs
StatePublished - Aug 1990
Externally publishedYes

Fingerprint

Human Herpesvirus 1
Giant Cells
Virus Replication
Viruses
Cycloheximide
Neutralizing Antibodies
Fluorescent Antibody Technique
tromantadine
Glycoproteins
Proteins
Infection

Keywords

  • Fusion
  • HSV-1
  • Syncytium formation
  • Tromantadine

ASJC Scopus subject areas

  • Pharmacology
  • Virology

Cite this

Tromantadine inhibits a late step in herpes simplex virus type 1 replication and syncytium formation. / Ickes, Dawn E.; Venetta, Tom M.; Phonphok, Yupa; Rosenthal, Ken S.

In: Antiviral Research, Vol. 14, No. 2, 08.1990, p. 75-85.

Research output: Contribution to journalArticle

Ickes, Dawn E. ; Venetta, Tom M. ; Phonphok, Yupa ; Rosenthal, Ken S. / Tromantadine inhibits a late step in herpes simplex virus type 1 replication and syncytium formation. In: Antiviral Research. 1990 ; Vol. 14, No. 2. pp. 75-85.
@article{1623e1760d0a4270a76cd279c2d9117d,
title = "Tromantadine inhibits a late step in herpes simplex virus type 1 replication and syncytium formation",
abstract = "Addition of tromantadine after virus penetration inhibited HSV-1 induced syncytium formation and virus production in HEp-2 and VERO cells and acted additively with neutralizing antibody in blocking virus spread and cytopathology. Inhibition of syncytium formation in VERO cells infected with 0.01 pfu/cell of HSV-1 GC+ was observed at a concentration <25 μg/ml. The extent of inhibition was dependent upon the multiplicity of infection and cell type. Tromantadine inhibited a late event in HSV-1 replication which appeared to be sensitive to cycloheximide. Reversal of the inhibitory effect of tromantadine on syncytium formation required new protein synthesis. HSV-1 gB, gC, and gD were synthesized in the presence of tromantadine and could be detected on the cell surface by immunofluorescence. Tromantadine most likely inhibits a cellular process that is required for syncytium formation, such as glycoprotein processing, which occurs after the synthesis of the fusion protein but before its expression on the cell surface.",
keywords = "Fusion, HSV-1, Syncytium formation, Tromantadine",
author = "Ickes, {Dawn E.} and Venetta, {Tom M.} and Yupa Phonphok and Rosenthal, {Ken S.}",
year = "1990",
month = "8",
doi = "10.1016/0166-3542(90)90045-9",
language = "English (US)",
volume = "14",
pages = "75--85",
journal = "Antiviral Research",
issn = "0166-3542",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Tromantadine inhibits a late step in herpes simplex virus type 1 replication and syncytium formation

AU - Ickes, Dawn E.

AU - Venetta, Tom M.

AU - Phonphok, Yupa

AU - Rosenthal, Ken S.

PY - 1990/8

Y1 - 1990/8

N2 - Addition of tromantadine after virus penetration inhibited HSV-1 induced syncytium formation and virus production in HEp-2 and VERO cells and acted additively with neutralizing antibody in blocking virus spread and cytopathology. Inhibition of syncytium formation in VERO cells infected with 0.01 pfu/cell of HSV-1 GC+ was observed at a concentration <25 μg/ml. The extent of inhibition was dependent upon the multiplicity of infection and cell type. Tromantadine inhibited a late event in HSV-1 replication which appeared to be sensitive to cycloheximide. Reversal of the inhibitory effect of tromantadine on syncytium formation required new protein synthesis. HSV-1 gB, gC, and gD were synthesized in the presence of tromantadine and could be detected on the cell surface by immunofluorescence. Tromantadine most likely inhibits a cellular process that is required for syncytium formation, such as glycoprotein processing, which occurs after the synthesis of the fusion protein but before its expression on the cell surface.

AB - Addition of tromantadine after virus penetration inhibited HSV-1 induced syncytium formation and virus production in HEp-2 and VERO cells and acted additively with neutralizing antibody in blocking virus spread and cytopathology. Inhibition of syncytium formation in VERO cells infected with 0.01 pfu/cell of HSV-1 GC+ was observed at a concentration <25 μg/ml. The extent of inhibition was dependent upon the multiplicity of infection and cell type. Tromantadine inhibited a late event in HSV-1 replication which appeared to be sensitive to cycloheximide. Reversal of the inhibitory effect of tromantadine on syncytium formation required new protein synthesis. HSV-1 gB, gC, and gD were synthesized in the presence of tromantadine and could be detected on the cell surface by immunofluorescence. Tromantadine most likely inhibits a cellular process that is required for syncytium formation, such as glycoprotein processing, which occurs after the synthesis of the fusion protein but before its expression on the cell surface.

KW - Fusion

KW - HSV-1

KW - Syncytium formation

KW - Tromantadine

UR - http://www.scopus.com/inward/record.url?scp=0025045669&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025045669&partnerID=8YFLogxK

U2 - 10.1016/0166-3542(90)90045-9

DO - 10.1016/0166-3542(90)90045-9

M3 - Article

C2 - 2177318

AN - SCOPUS:0025045669

VL - 14

SP - 75

EP - 85

JO - Antiviral Research

JF - Antiviral Research

SN - 0166-3542

IS - 2

ER -